Menstrual pattern changes from levonorgestrel subdermal implants and DMPA: systematic review and evidence-based comparisons

Contraception

Volumn 80, Issue 2, 2009, Pages 113-118

  Hubacher, David ^a   Lopez, Laureen ^a   Steiner, Markus J ^a   Dorflinger, Laneta ^a  

^a FAMILY HEALTH INTERNATIONAL   (United States)

Author keywords

Comparison; Depot medroxyprogesterone acetate; DMPA; Levonorgestrel subdermal implant; Menstrual diaries; Norplant; Side effects

Indexed keywords

LEVONORGESTREL; MEDROXYPROGESTERONE ACETATE;

AMENORRHEA; CLINICAL TRIAL; DISEASE DURATION; DRUG IMPLANT; HORMONAL CONTRACEPTION; HUMAN; INTERMETHOD COMPARISON; MENSTRUAL IRREGULARITY; MENSTRUATION; REVIEW; SPOTTING; SYSTEMATIC REVIEW; VAGINA BLEEDING; WORLD HEALTH ORGANIZATION;

CONTRACEPTIVE AGENTS, FEMALE; DRUG IMPLANTS; FEMALE; HUMANS; LEVONORGESTREL; MEDICATION ADHERENCE; MEDROXYPROGESTERONE 17-ACETATE; MENSTRUATION DISTURBANCES;

EID: 67651024133     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2009.02.008     Document Type: Review

References (47)

1. Rodriguez G., Faundes A., and Atkinson L.L. An approach to the analysis of menstrual patterns in the critical evaluation of contraceptives. Stud Fam Plann 7 (1976) 42-51
2. Belsey E.M., Machin D., and d'Arcangues C. The analysis of vaginal bleeding patterns induced by fertility regulating methods. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction. Contraception 34 (1986) 253-260
3. Mullee M.A., Machin D., and d'Arcangues C. A bibliography of the statistical analysis of vaginal bleeding patterns. Contraception 38 (1988) 259-285
4. Belsey E.M., and Carlson N. The description of menstrual bleeding patterns: towards fewer measures. Stat Med 10 (1991) 267-284
5. Sivin I., Campodonico I., Kiriwat O., Holma P., Diaz S., Wan L., et al. The performance of levonorgestrel rod and Norplant contraceptive implants: a 5 year randomized study. Hum Reprod 13 (1998) 3371-3378
6. Sivin I., Viegas O., Campodonico I., Diaz S., Pavez M., Wan L., et al. Clinical performance of a new two-rod levonorgestrel contraceptive implant: a three-year randomized study with Norplant implants as controls. Contraception 55 (1997) 73-80
7. del Carmen Cravioto M., Alvarado G., Canto-de-Cetina T., Bassol S., Oropeza G., Santos-Yung R., et al. A multicenter comparative study on the efficacy, safety, and acceptability of the contraceptive subdermal implants Norplant and Norplant-II. Contraception 55 (1997) 359-367
8. Power J., French R., and Cowan F. Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods of preventing pregnancy. Cochrane Database Syst Rev (2007) CD001326
9. Zheng S.R., Zheng H.M., Qian S.Z., Sang G.W., and Kaper R.F. A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant. Contraception 60 (1999) 1-8
10. Affandi B. An integrated analysis of vaginal bleeding patterns in clinical trials of Implanon. Contraception 58 (1998) 99S-107S
11. Rekers H., and Affandi B. Implanon studies conducted in Indonesia. Contraception 70 (2004) 433
12. Salem H.T., Salah M., Aly M.Y., Thabet A.I., Shaaban M.M., and Fathalla M.F. Acceptability of injectable contraceptives in Assiut, Egypt. Contraception 38 (1988) 697-710
13. Shaaban M.M., Salah M., Zarzour A., and Abdullah S.A. A prospective study of NORPLANT implants and the TCu 380AgIUD in Assiut, Egypt. Stud Fam Plann 14 (1983) 163-169
14. Olsson S.E., Odlind V., Johansson E.D., and Sivin I. Contraception with NORPLANT implants and NORPLANT-2 implants (two covered rods). Results from a comparative clinical study in Sweden. Contraception 37 (1988) 61-73
15. Sivin I. International experience with NORPLANT and NORPLANT-2 contraceptives. Stud Fam Plann 19 (1988) 81-94
16. Fakeye O., and Balogh S. Effect of Norplant contraceptive use on hemoglobin, packed cell volume and menstrual bleeding patterns. Contraception 39 (1989) 265-274
17. Shoupe D., Mishell Jr. D.R., Bopp B.L., and Fielding M. The significance of bleeding patterns in Norplant implant users. Obstet Gynecol 77 (1991) 256-260
18. Singh K., Viegas O.A., Liew D., Singh P., and Ratnam S.S. Norplant-2 rods: one year experience in Singapore. Contraception 38 (1988) 429-440
19. Faundes A., Sivin I., and Stern J. Long acting contraceptive implants. An analysis of menstrual bleeding patterns. Contraception 18 (1978) 355-365
20. Ruminjo J.K., Sekadde-Kigondu C.B., Karanja J.G., Rivera R., Nasution M., and Nutley T. Comparative acceptability of combined and progestin-only injectable contraceptives in Kenya. Contraception 72 (2005) 138-145
21. Wang S.L., Wu S.C., Xin X.M., Chen J.H., and Gao J. Three years' experience with levonorgestrel-releasing intrauterine device and Norplant-2 implants: a randomized comparative study. Adv Contracept 8 (1992) 105-114
22. Fraser I.S. Vaginal bleeding patterns in women using once-a-month injectable contraceptives. Contraception 49 (1994) 399-420
23. Du M.K., Chen C.H., and Zheng H.M. An analysis of vaginal bleeding patterns in users of Norplant implants. J Reprod Contracept 9 (1998) 11-18
24. Belsey E.M. Menstrual bleeding patterns in untreated women and with long-acting methods of contraception. Task Force on Long-Acting Systemic Agents for Fertility Regulation. Adv Contracept 7 (1991) 257-270
25. Cuong D.T., and My Huong N.T. Comparative phase III clinical trial of two injectable contraceptive preparations, depot-medroxyprogesterone acetate and Cyclofem, in Vietnamese women. Contraception 54 (1996) 169-179
26. Mainwaring R., Hales H.A., Stevenson K., Hatasaka H.H., Poulson A.M., Jones K.P., et al. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives. Contraception 51 (1995) 149-153
27. Simbar M., Tehrani F.R., Hashemi Z., Zham H., and Fraser I.S. A comparative study of Cyclofem and depot medroxyprogesterone acetate (DMPA) effects on endometrial vasculature. J Fam Plann Reprod Health Care 33 (2007) 271-276
28. World Health Organization. Multinational comparative clinical evaluation of two long-acting injectable contraceptive steroids: norethisterone oenanthate and medroxyprogesterone acetate. 2. Bleeding patterns and side effects. Contraception 17 (1978) 395-406
29. Said S., Omar K., Koetsawang S., Kiriwat O., Srisatayapan Y., Kazi A., et al. A multicentered phase III comparative clinical trial of depot-medroxyprogesterone acetate given three-monthly at doses of 100 mg or 150 mg: II. The comparison of bleeding patterns. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation Special Programme of Research, Development and Research Training in Human Reproduction. Contraception 35 (1987) 591-610
30. Aisien A.O., Sagay A.S., Imade G.E., Ujah I.A., and Nnana O.U. Changes in menstrual and haematological indices among Norplant acceptors. Contraception 61 (2000) 283-286
31. Balogh S.A., Klavon S.L., Basnayake S., Puertollano N., Ramos R.M., and Grubb G.S. Bleeding patterns and acceptability among Norplant users in two Asian countries. Contraception 39 (1989) 541-553
32. Biswas A., Leong W.P., Ratnam S.S., and Viegas O.A. Menstrual bleeding patterns in Norplant-2 implant users. Contraception 54 (1996) 91-95
33. Chompootaweep S., Kochagarn E., Sirisumpan S., Tang-usaha J., Theppitaksak B., and Dusitsin N. Effectiveness of Norplant implants among Thai women in Bangkok. Contraception 53 (1996) 33-36
34. Chompootaweep S., Kochagarn E., Tang-Usaha J., Theppitaksak B., and Dusitsin N. Experience of Thai women in Bangkok with Norplant-2 implants. Contraception 58 (1998) 221-225
35. Datey S., Gaur L.N., and Saxena B.N. Vaginal bleeding patterns of women using different contraceptive methods (implants, injectables, IUDs, oral pills) - an Indian experience. An ICMR Task Force Study. Indian Council of Medical Research. Contraception 51 (1995) 155-165
36. Du M.K., Zheng H.M., Chen H.C., and Chow L.P. Study of Norplant implants in Shanghai: three-year experience. Int J Gynaecol Obstet 33 (1990) 345-357
37. Fraser I.S., Weisberg E., Minehan E., and Johansson E.D. A detailed analysis of menstrual blood loss in women using Norplant and Nestorone progestogen-only contraceptive implants or vaginal rings. Contraception 61 (2000) 241-251
38. Gao J., Wang S.L., Wu S.C., Sun B.L., Allonen H., and Luukkainen T. Comparison of the clinical performance, contraceptive efficacy and acceptability of levonorgestrel-releasing IUD and Norplant-2 implants in China. Contraception 41 (1990) 485-494
39. Pasquale S.A., Knuppel R.A., Owens A.G., and Bachmann G.A. Irregular bleeding, body mass index and coital frequency in Norplant contraceptive users. Contraception 50 (1994) 109-116
40. Treloar A.E., Boynton R.E., Behn B.G., and Brown B.W. Variation of the human menstrual cycle through reproductive life. Int J Fertil 12 (1967) 77-126
41. Belsey E.M., and Pinol A.P. Menstrual bleeding patterns in untreated women. Task Force on Long-Acting Systemic Agents for Fertility Regulation. Contraception 55 (1997) 57-65
42. Garza-Flores J., Hall P.E., and Perez-Palacios G. Long-acting hormonal contraceptives for women. J Steroid Biochem Mol Biol 40 (1991) 697-704
43. Belsey E.M., and Peregoudov S. Determinants of menstrual bleeding patterns among women using natural and hormonal methods of contraception. I. Regional variations. Contraception 38 (1988) 227-242
44. Belsey E.M. Vaginal bleeding patterns among women using one natural and eight hormonal methods of contraception. Contraception 38 (1988) 181-206
45. Machin D., Farley T.M., Busca B., Campbell M.J., and d'Arcangues C. Assessing changes in vaginal bleeding patterns in contracepting women. Contraception 38 (1988) 165-179
46. Mishell Jr. D.R., Guillebaud J., Westhoff C., Nelson A.L., Kaunitz A.M., Trussell J., et al. Recommendations for standardization of data collection and analysis of bleeding in combined hormone contraceptive trials. Contraception 75 (2007) 11-15
47. Mishell Jr. D.R., Guillebaud J., Westhoff C., Nelson A.L., Kaunitz A.M., Trussell J., et al. Combined hormonal contraceptive trials: variable data collection and bleeding assessment methodologies influence study outcomes and physician perception. Contraception 75 (2007) 4-10